Anavex Life Sciences Corp. (AVXL)
NASDAQ·Healthcare·Biotechnology
$1.14
-1.30%
Mkt Cap $106.60M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+869.2%
Consensus $11.00 vs current $1.14
NASDAQ·Healthcare·Biotechnology
$1.14
-1.30%
Mkt Cap $106.60M
No recent rating data.
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
+869.2%
Consensus $11.00 vs current $1.14